Successful Deals with PwC: ADQ to acquire Swiss pharma company Acino

ADQ, one of Abu Dhabi’s largest holding companies, will acquire 100% of Acino from its current shareholders, Nordic Capital and Avista Capital Partners.

Acino is a Swiss-based leading provider of pharmaceuticals with presence in more than 90 countries across the Middle East, Africa, Latin America, Russia, Ukraine and the CIS Region. The company is a leader in more than 20 therapeutic areas including gastroenterology, cardiovascular and pain relief for high-quality pharmaceutical products in novel drug delivery forms.

Acino will be ADQ’s largest acquisition in its healthcare and pharma portfolio.

The PwC Deals team supported Acino and its current shareholders with Financial Vendor Due Diligence and a Tax Fact Book.

The PwC team

Financial and Pension Vendor Due Diligence

Simon Bradford
Luca Borrelli
Leonor Lefebvre
Felix Peters
Markus Schneeberger
Kristi Leibur-Nagel
Andreas Schuler
Janko Mahecic

Tax Fact Book

Claire Manders Avanzini
Ariel Gruenewald

Support from PwC South Africa and Ukraine teams.

Successful Deals with PwC

100 results

03/04/25

BPM Group acquires Groupe Leuba

PwC provided financial due diligence, tax due diligence and legal due diligence as well as financial advisory services to BPM Switzerland.

26/03/25

Crédit Mutuel Alliance Fédérale agrees to acquire Oldenburgische Landesbank

PwC supported the shareholders and the OLB platform across all acquisitions and mergers with multiple teams from various jurisdictions and lines of services, making this success story a testament to our firm and our strong capabilities throughout the deals cycle.

21/01/25

KARL STORZ acquires Anklin

The Corporate Finance/M&A team is pleased to announce the sale of Anklin AG (“Anklin”) to KARL STORZ SE & Co. KG (“KARL STORZ”). PwC supported Anklin as lead financial advisor.

14/01/25

4B sold to Dovista A/S

The PwC Deals team is pleased to announce that 4B, the Swiss market leader for windows and facades based in Hochdorf, will become part of the Danish group Dovista.

17/12/24

EBL plans to take over ECOGEN Rigi and acquire a majority stake in AGRO Energiezentrum Rigi

The PwC Deals team is pleased to announce that EBL plans to take over ECOGEN Rigi and acquire a majority stake in AGRO Energiezentrum Rigi.

17/12/24

Aebi Schmidt Group to merge with The Shyft Group

The PwC Deals team is pleased to announce that Aebi Schmidt Group and The Shyft Group (NASDAQ: SHYF) announced a definitive agreement to combine in an all-stock merger.

26/11/24

Adragos Pharma GmbH acquires Baccinex SA

Our support involved providing buy-side due diligence support (financial, tax and pension due diligence) as well as structuring and SPA advice to Adragos Pharma GmbH.

14/11/24

Swissport acquires ViaEurope

Our support involved X-LoS and X-jurisdiction Deals teams providing Financial and Tax Due Diligence, Tax Structuring and SPA negotiations advice.

Contact us

Simon Bradford

Partner, PwC Switzerland

Tel: +41 79 595 68 84

Luca Borrelli

Partner, Deals Pharma and Life Sciences Leader, PwC Switzerland

Tel: +41 58 792 22 78